Navigation Links
Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
Date:3/18/2008

REDWOOD CITY, Calif., March 18 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, has announced that they have extended and expanded their existing license agreement with GlaxoSmithKline for access to Ingenuity Pathways Analysis (IPA) software. The new agreement enables GSK to provide enterprise-wide IPA access to researchers for rapid assessment of the signaling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets. In addition, GSK will also use Ingenuity's content and proprietary algorithms.

"We are very pleased that GSK will now be able to leverage IPA and other Ingenuity information solutions at the enterprise level," stated Jake Leschly, CEO, Ingenuity Systems. "Many discovery programs at GSK have already successfully used IPA to understand the complex relationship between pathways and disease. Research teams across the organization will now be able to use these insights to make effective decisions as to which drug targets and compounds to pursue."

About Ingenuity Pathways Analysis

Ingenuity Pathways Analysis is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA's search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals.

About Ingenuity Systems(R)

Ingenuity Systems is a leading provid
'/>"/>

SOURCE Ingenuity Systems(R)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ingenuity Systems Launches New Metabolomics Solution Within IPA
2. Ingenuity Systems Joins Biomarkers Consortium
3. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
4. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
5. DNA Testing Systems Inks Agreement with DNAPrint Genomics
6. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
7. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
8. Purdue leads center to simulate behavior of micro-electromechanical systems
9. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
10. IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology
11. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/--BiotechfirmReplikinsLtd.,whichhasanalyze...htheprediction,outbreak,andprogressofthecurrentH1N...fthevirus.ThenewdatashowsthatthelethalityoftheH1N1...5)duringthevirus,scurrentoutbreakinthespringof2009...TheH1N1virus,infectivitycount,however,remainsincre...
(Date:11/25/2009)...Newswire/--Reportlinker.comannouncesthatanewmarket...azilBioethanolMarketAnalysisandForecaststo2013 ,...ioethanol-Market-Analysis-and-Forecasts-to-2013.ht...tsto2013 ,, Summary ,, Thereportprovidesde...ketandtheBrazilbioethanolmarketinparticular.Italso...
(Date:11/24/2009)... The New York investment bank KTA Capital,s client...n AU$6.7 mil convertible note private placement wi...ement was arranged by KTA Capital as Neuren,s excl... New York (PRWEB) November 23, 2009 -- ...al, LLC ("KTA Capital") has announced th...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in O... consistent growth during the U.S. recession. Howe...uble, and health systems are coming closer to havi...ust administrators. , (Vo...ontinued growing in October despite the shedding o...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...y came into CUNA Mutual Groups IT shop, he wasnt c...s predecessor, Steve Haroldson, retired leaving it...usiness and was delivering on its operational prom...needed a sophisticated approach to build on these ... when you tie IT to financial services, the situat...
...s. NimbleGen , a Madison biotech firm that play...e 2003 Severe Acute Respiratory Syndrome outbreak ...tal. , ,The company has raised a total of $41 mill...chairman of NimbleGens board, expects the company ...cro-array technology. He said there is a $700 mill...
...ave approved putting their state into further debt...ng, 59 percent of California voters approved Propo...ch grants over the next decade. , ,The proposition...arzenegger in mid-October, establishes a Californi...te will be able to provide stem-cell researchers u...
Other Biology Technology:CIO of CUNA Mutual Group talks on business-IT fusion 2CIO of CUNA Mutual Group talks on business-IT fusion 3Wisconsin company with SARS diagnostic role lands $13 million investment 2Californians: Stem cells important enough to go into debt for 2
(Date:11/24/2009)...arch Institute (LRI) today named 12 new grant reci..., recognize innovative work across a broad spectru...reativity, novelty, and potential to drive scienti...re the complex disease of systemic lupus. , The ...esearchers across the nation and include interdisc...
(Date:11/24/2009)...ep weakened and flabby arteries from collapsing ha...ose stents are no longer needed -- once the arteri...iously, doctors had no choice but to leave them in...versity,s Department of Biomedical Engineering has...t carries drugs where they,re needed, then dissolv...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife Con...evealing that the last remaining population of Sib... to the rising tide of poaching and habitat loss. ...rm Russian officials of what needs to be done to p...t cat. , The report was released by...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2FRC Calls on President Obama Speaker Pelosi and Senator Reid to Repudiate Diana DeGettes Religious Bigotry 61579 1FRC Calls on President Obama Speaker Pelosi and Senator Reid to Repudiate Diana DeGettes Religious Bigotry 61579 2American College of Cardiology American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel a 61574 1American College of Cardiology American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel a 61574 2Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 1Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 2Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 3Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 4
... SALT LAKE CITY Sandcastle worms live in intert...bits of sand and shell and their own natural glue....etic version of this seaworthy superglue, and hope...attered bones in knees, other joints and the face....ther," says Russell Stewart, associate professor o...
... , A new bilingual online information system creat...ithsonian Tropical Research Institute, and Coeus K...nists, sport fishers, tourists, researchers, stude... publishable maps for 1,287 tropical eastern Pacif... Eastern Pacific Online Information System is host...
... GAINESVILLE, Fla. The vacancy sign is on, but t...tists at the University of Florida and the Univers...heres that trap and kill harmful bacteria in a man... and killing cockroaches. The research could lead ...s, combat bioterrorism or sterilize medical device...
Other Biology News:Superglue from the sea 2Superglue from the sea 3Superglue from the sea 4Superglue from the sea 5Smithsonian puts tropical Eastern-Pacific shore fishes online 2Smithsonian puts tropical Eastern-Pacific shore fishes online 3Scientists build 'roach motel' for nasty bugs of the bacterial variety 2
Printer Paper for Model 680 Series Readers, 2 rolls from Bio-Rad
... used for vertical electrophoresis applications. T...uires 1.2 L of running buffer. It includes the PRO...n kit, which contains accessories for use with 2.0...2 sets of 20 x 20 cm glass plates, 4 IPG spacers, ...
PROTEAN II XL Cell, wide format from Bio-Rad
StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
Biology Products: